Shih-Wei Wang Selected Research

Trichodermin

9/2022	Trichodermin inhibits the growth of oral cancer through apoptosis-induced mitochondrial dysfunction and HDAC-2-mediated signaling.
1/2017	Trichodermin induces c-Jun N-terminal kinase-dependent apoptosis caused by mitotic arrest and DNA damage in human p53-mutated pancreatic cancer cells and xenografts.
10/2013	Trichodermin induces cell apoptosis through mitochondrial dysfunction and endoplasmic reticulum stress in human chondrosarcoma cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Shih-Wei Wang Research Topics

Disease

63	Neoplasms (Cancer) 12/2023 - 02/2010
36	Neoplasm Metastasis (Metastasis) 12/2023 - 11/2007
23	Chondrosarcoma 11/2022 - 10/2013
13	Hepatocellular Carcinoma (Hepatoma) 12/2023 - 03/2005
10	Prostatic Neoplasms (Prostate Cancer) 12/2023 - 01/2014
9	Osteosarcoma (Osteogenic Sarcoma) 12/2023 - 01/2012
8	Rheumatoid Arthritis 01/2022 - 01/2012
7	Inflammation (Inflammations) 12/2022 - 01/2017
7	Osteoarthritis 01/2022 - 01/2020
7	Experimental Arthritis 01/2022 - 07/2015
5	Lymphatic Metastasis 01/2018 - 01/2014
5	Hypoxia (Hypoxemia) 01/2017 - 01/2015
5	Carcinogenesis 01/2017 - 12/2014
4	Infections 09/2023 - 01/2021
4	Lung Neoplasms (Lung Cancer) 01/2023 - 06/2010
4	Mouth Neoplasms (Oral Cancer) 09/2022 - 01/2018
4	Squamous Cell Carcinoma of Head and Neck 07/2022 - 02/2015
4	Obesity 01/2020 - 10/2017
3	Melanoma (Melanoma, Malignant) 12/2023 - 12/2015
3	Mitochondrial Diseases (Mitochondrial Disease) 11/2023 - 10/2013
3	Atrial Fibrillation 01/2022 - 01/2021
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2021 - 04/2014
2	Colorectal Neoplasms (Colorectal Cancer) 11/2023 - 04/2022
2	Chronic Renal Insufficiency 01/2022 - 01/2021
2	Stroke (Strokes) 01/2022 - 01/2021
2	Embolism (Embolus) 01/2022 - 01/2021
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2020
2	Disease Progression 03/2021 - 04/2019
2	Pain (Aches) 01/2021 - 07/2017
2	Pathologic Processes 01/2020 - 01/2020
1	Sarcoma (Soft Tissue Sarcoma) 11/2023
1	COVID-19 09/2023
1	Myocardial Infarction 02/2023
1	Ischemic Stroke 02/2023
1	Heart Failure 02/2023

Drug/Important Bio-Agent (IBA)

36	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 05/2023 - 12/2011
12	Vascular Endothelial Growth Factor CIBA 01/2023 - 01/2014
11	CytokinesIBA 10/2022 - 01/2012
10	Proteins (Proteins, Gene)FDA Link 09/2023 - 02/2013
10	AdipokinesIBA 01/2023 - 12/2014
9	Small Interfering RNA (siRNA)IBA 01/2022 - 01/2012
8	erucylphosphocholineIBA 01/2023 - 01/2016
8	ResistinIBA 08/2021 - 07/2015
7	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 11/2022 - 10/2014
5	buteinIBA 05/2023 - 07/2012
5	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 07/2022 - 01/2012
5	Chemokine CCL5IBA 06/2016 - 01/2012
4	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 12/2023 - 07/2015
4	Transcription Factor AP-1 (Transcription Factor AP 1)IBA 12/2023 - 02/2013
4	Nicotinamide PhosphoribosyltransferaseIBA 01/2023 - 01/2020
4	4-acetylantroquinonol BIBA 01/2022 - 01/2015
4	AdiponectinIBA 10/2021 - 11/2015
4	Transcription Factors (Transcription Factor)IBA 10/2021 - 03/2007
4	Conditioned Culture MediaIBA 09/2021 - 01/2015
4	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 02/2008
4	AmphiregulinIBA 01/2020 - 01/2017
3	MelatoninIBA 01/2023 - 01/2021
3	Platelet-Derived Growth FactorIBA 11/2022 - 12/2019
3	TrichoderminIBA 09/2022 - 10/2013
3	LigandsIBA 07/2022 - 01/2017
3	CC ChemokinesIBA 07/2022 - 11/2014
3	MicroRNAs (MicroRNA)IBA 04/2022 - 02/2015
3	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 10/2021 - 09/2014
3	LeptinIBA 08/2021 - 12/2014
3	Cysteine (L-Cysteine)FDA Link 03/2021 - 10/2017
3	ApelinIBA 01/2021 - 01/2020
3	matrigelIBA 11/2015 - 10/2014
2	Glutaral (Glutaraldehyde)IBA 11/2023 - 01/2021
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2023 - 01/2021
2	Denosumab FDA Link 02/2023 - 06/2019
2	Aldehyde DehydrogenaseIBA 01/2023 - 10/2021
2	Histones (Histone)IBA 01/2023 - 01/2018
2	Angiopoietin-2IBA 07/2022 - 10/2017
2	Chemokine CCL4IBA 07/2022 - 01/2018
2	IntegrinsIBA 04/2022 - 01/2012
2	MT1 Melatonin ReceptorIBA 04/2022 - 01/2021
2	Type C PhospholipasesIBA 10/2021 - 01/2021
2	dendrophenolIBA 03/2021 - 06/2010
2	Hormones (Hormone)IBA 01/2021 - 01/2018
2	MitogensIBA 12/2020 - 01/2016
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 04/2019
2	EnzymesIBA 12/2019 - 10/2017
2	JNK Mitogen-Activated Protein KinasesIBA 11/2019 - 01/2017
2	LipidsIBA 04/2019 - 01/2018
2	ErbB Receptors (EGF Receptor)IBA 01/2017 - 12/2011
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2017 - 10/2014
1	Glucose (Dextrose)FDA LinkGeneric 12/2023
1	cryptocaryoneIBA 12/2023
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 12/2023
1	Cell Adhesion MoleculesIBA 12/2023
1	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 12/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2023
1	chaetoglobosinsIBA 11/2023
1	Heme Oxygenase-1IBA 11/2023
1	Neutralizing AntibodiesIBA 09/2023
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 09/2023
1	asiatic acidIBA 07/2023
1	Raloxifene Hydrochloride (Evista)FDA Link 02/2023

Therapy/Procedure

16	Therapeutics 12/2023 - 06/2010
6	Drug Therapy (Chemotherapy) 11/2023 - 10/2013